This inventor holds 19 USPTO granted patents, primarily in Melanocortin Compounds. Top assignee: Palatin Technologies Incorporated. Active years: 2007-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2012
Areas of Expertise:
Title: Innovations in Melanocortin Research: The Contributions of Ramesh Rajpurohit
Introduction
Ramesh Rajpurohit, based in Hillsboro, NJ, is a prominent inventor specializing in the field of melanocortin receptor research. With an impressive portfolio of 19 patents, he has made significant contributions to the development of therapies for sexual dysfunction and related disorders. His work at Palatin Technologies Incorporated highlights the innovative approaches he has brought to the pharmaceutical industry.
Latest Patents
Ramesh's recent patents include groundbreaking advancements such as N-alkylated cyclic peptide melanocortin agonists and melanocortin receptor-specific compounds. The N-alkylated cyclic peptide patent introduces a novel cyclic peptide designed to function as a melanocortin-4 receptor agonist. This compound presents potential treatment methods for addressing sexual dysfunction, including male erectile dysfunction and female sexual dysfunction, along with various other conditions responsive to the melanocortin-4 receptor.
In the second patent related to melanocortin receptor-specific compounds, Ramesh describes a compound that binds with high affinity to one or more melanocortin receptors. This innovation allows for the compound to act as an agonist, antagonist, or inverse agonist, opening new avenues for the treatment of conditions associated with melanocortin receptors.
Career Highlights
Throughout his career, Ramesh has been instrumental in advancing scientific knowledge in the field of medicine and therapeutics. His inventive spirit and expertise have not only led to multiple patents but have also positioned him as a leading figure in the industry. His affiliation with Palatin Technologies Incorporated has allowed him to work on significant projects that could revolutionize treatment options in his field.
Collaborations
Ramesh regularly collaborates with fellow innovators such as Shubh D. Sharma and Yi-Qun Shi. These partnerships emphasize a collective commitment to scientific advancement and the development of effective therapies for pressing medical issues.
Conclusion
Ramesh Rajpurohit's contributions to the field of melanocortin research through his extensive patent portfolio reflect his dedication to innovation and improvement in healthcare. His work at Palatin Technologies Incorporated showcases the potential of scientific research in translating into real-world solutions for patients suffering from various disorders. As the field evolves, the impact of his inventions will undoubtedly continue to influence future developments in therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile